Fondazione Ricerca e Innovazione Cardiovascolare ETS (Fondazione RIC), a leading independent non-profit research foundation at the forefront of cardiovascular innovation, in collaboration with ...
From diabetes to cardiovascular disease, ignoring gender-specific risks may lead to delayed diagnosis and misdirected therapy in both women and men.
A research team led by Professors Joo-Yong Hahn, Young Bin Song, and Ki Hong Choi of the Division of Cardiology at Samsung ...
Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...
Background Coronary microvascular dysfunction (CMD) is associated with a poor prognosis but is difficult to diagnose non-invasively. In a recent paper, ST-segment depression on exercise-ECG was found ...
Comprehensive phosphorus management preserves residual renal function, considers dialysis modality, and minimizes intervention burden.
Background The limited literature provides minimal information on clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) under different healthcare funding systems, ...
(UM SRH) has earned multiple American Heart Association (AHA) awards recognizing its commitment to delivering high-quality, ...
Patients with treatment-naive neovascular age-related macular degeneration have positive outcomes with faricimab at 1 year, ...
Military service members and veterans frequently experience post-traumatic stress disorder (PTSD), which is linked to a range of psychological challenges and adverse effects. Cognitive-behavioral ...
Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...
Treatment with a JAK inhibitor should be standard of care for any patient with alopecia areata who desires it, even if their hair loss is less than 50%, according to a speaker at South Beach Symposium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results